This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Suncadia Pharmaceuticals Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Defu Song: Innovator in Pharmaceutical Chemistry
Introduction
Defu Song is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of Ticagrelor, a medication used to reduce the risk of heart attacks and strokes.
Latest Patents
Defu Song holds a patent for the "Intermediate of Ticagrelor and preparation method therefor, and preparation method for Ticagrelor." This patent discloses intermediates of Ticagrelor and a preparation method for the drug. Specifically, it introduces a compound of Formula (VI) that is essential for preparing Ticagrelor. The method simplifies the synthesis process, avoiding the long reaction times and high temperatures required in existing methods. This innovation is suitable for mass production, reduces energy consumption, minimizes environmental pollution, and decreases waste discharge.
Career Highlights
Throughout his career, Defu Song has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Suncadia Pharmaceuticals Co., Ltd. His work in these organizations has contributed to advancements in drug development and production.
Collaborations
Defu Song has collaborated with notable colleagues, including Shaoguang Sun and Biao He. These partnerships have fostered innovation and progress in their respective fields.
Conclusion
Defu Song's contributions to pharmaceutical chemistry, particularly through his patent on Ticagrelor, highlight his role as an innovator in the industry. His work not only advances medical science but also emphasizes the importance of sustainable practices in drug production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile